conivaptan has been researched along with Ascites in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arroyo, V; Cano, C; Cejudo-Martín, P; Fernández-Varo, G; Jiménez, W; Rivera, F; Rodés, J; Ros, J | 1 |
| Ginès, P; Guevara, M; Martín-Llahí, M | 1 |
| Cárdenas, A; Ginès, P | 1 |
2 review(s) available for conivaptan and Ascites
| Article | Year |
|---|---|
Hyponatremia in cirrhosis: clinical features and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Brain; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Creatinine; Forecasting; Hepatic Encephalopathy; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Prognosis; Research; Risk Factors; Sodium; Time Factors; Treatment Outcome | 2006 |
The management of ascites and hyponatremia in cirrhosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diet, Sodium-Restricted; Diuretics; Humans; Hyponatremia; Liver Cirrhosis; Prognosis | 2008 |
1 other study(ies) available for conivaptan and Ascites
| Article | Year |
|---|---|
Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diuresis; Drug Administration Schedule; Hemodynamics; Kidney; Liver Cirrhosis; Male; Natriuresis; Osmolar Concentration; Rats; Rats, Wistar; Sodium; Urine; Water | 2003 |